Due to their potential adverse health effects, some N-nitrosamines in drug products are strictly regulated with very low maximum daily intake limits. Nitrosamines can be formed from the reaction of nitrite and secondary or tertiary amines when both species co-exist in the drug synthesis or formulation process. One key strategy to mitigate nitrosamine risk in drugs is to select low-nitrite containing pharma excipients for formulation.
View Article and Find Full Text PDFRegulatory authorities like the U.S. Food and Drug Administration (FDA) have set strict specification levels for N-nitrosamines in finished drug products.
View Article and Find Full Text PDFFood Addit Contam Part A Chem Anal Control Expo Risk Assess
December 2022
Ethylene oxide (EtO) is naturally present in numerous food products but recently EtO and its degradation product of 2-chloroethanol (2-CE) have been reported in amounts exceeding the maximum residue limit in Europe. The reports include hard capsules for dietary supplements made from low viscous hydroxypropyl methylcellulose (HPMC). The European council (EC) has proposed a generalized method for spices, seeds, and capsules utilizing QuEChERS, solid phase extraction (SPE), and GC-MS/MS to accommodate the need for analyte specificity, trace-level analysis, and higher throughput.
View Article and Find Full Text PDF